(Q68813954)
Statements
Immunotherapy of intraperitoneal cancer with interleukin 2 and lymphokine-activated killer cells reduces tumor load and prolongs survival in murine models (English)
R T Ottow
E P Steller
P H Sugarbaker
R A Wesley
1 February 1987